COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials
Axiodis CRO, a subsidiary of Oxurion NV, leverages AI to enhance clinical trials with digital twins for disease simulation and AI modules integrated into Exagis eCRF solution for improved data quality and workflow efficiency -
COMMUNIQUÉ DE PRESSE
Axiodis CRO, de Franse dochtervennootschap van de Oxurion-groep, kondigt een dubbele strategische AI-initiatieven aan om klinische proeven te transformeren
Axiodis CRO, een dochteronderneming van Oxurion, lanceert digitale tweelingen en integreert AI in eCRF-oplossing Exagis om klinische studies te versnellen en te beveiligen -
-
-
-
COMMUNIQUÉ DE PRESSE
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding change in shareholding. Oxurion specializes in acquiring majority stakes in European pharmaceutical subcontractors -
-
-
